Literature DB >> 25043617

On the choice of degrees of freedom for testing gene-gene interactions.

Masao Ueki1.   

Abstract

In gene-gene interaction analysis using single nucleotide polymorphism (SNP) data, empty cells arise in the genotype contingency table more frequently than in single SNP association studies. Empty cells lead to unidentifiable regression coefficients in regression model fitting. It is unclear whether the degrees of freedom (d.f.) for testing interactions are reduced for such sparse contingency tables. Boolean Operation based Screening and Testing is an exhaustive gene-gene interaction search method in which a fixed d.f. of four (the most conservative choice) is used in the chi-squared null distribution for the likelihood ratio test for gene-gene interactions under a logistic regression model. In this paper, the choice of d.f. is investigated theoretically by introducing a decomposition of type I error. An adaptive method using the observed d.f. can be less conservative than the fixed d.f. method, thereby enhancing power. In simulated data, type I error rates for the adaptive method were usually better controlled under various scenarios for Gaussian linear regression and logistic regression, including prospective and retrospective sampling designs, as well as for artificial data that mimic actual genome-wide SNPs. When the adaptive method was applied to public datasets generated from simulations, it exhibited an improvement in power over the fixed method.
Copyright © 2014 John Wiley & Sons, Ltd.

Keywords:  decomposition of type I error; degrees of freedom; gene-gene interaction; prospective sampling; retrospective sampling

Mesh:

Year:  2014        PMID: 25043617     DOI: 10.1002/sim.6264

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  1 in total

1.  Fast score test with global null estimation regardless of missing genotypes.

Authors:  Shuntaro Sato; Masao Ueki
Journal:  PLoS One       Date:  2018-07-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.